Skip to content

Pulmonary rehabilitation after minimal invasive surgery in lung cancer.

Pulmonary rehabilitation after minimal invasive surgery in lung cancer.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON26608
Enrollment
100
Registered
2018-12-10
Start date
2019-01-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer, post operative pain, VATS, RATS, longkanker

Interventions

Sponsors

Isala Zwolle
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients undergoing minimal invasive surgery for lung cancer, ages between 18 and 80 years. In order to be eligible to participate in this study, a subject must meet all of the following criteria: 1. Patients undergoing elective, minimal invasive surgery with intention to cure. 2. Age between 18 and 80 years. 3. ECOG 0 – 2 post-surgery.

Exclusion criteria

Exclusion criteria: 1. Patients with chronic pain 2. Previous pulmonary surgery 3. Comorbidity limiting rehabilitation a. Rheumatoid arthritis b. Severe ischaemic heart disease or myocardial failure; EF ≤ 35 %. c. Muscle disease d. Fibromyalgia e. Neurologic disorders (Parkinson disease, CVA and lesions of the spinal cord) f. Psychiatric disorders

Design outcomes

Primary

MeasureTime frame
To evaluate the effects of an integrated multidisciplinary rehabilitation program on general quality of life (short form 36, SF-36, subdomain general health) in the 12 months postoperative period in patients undergoing elective minimal invasive surgery in lung cancer.

Secondary

MeasureTime frame
To evaluate the effects of the program on health-related quality of life (SGRQ), post-operative pain (VAS), performance score (WHO-PS), exercise tolerance (6 minute walking distance, 6MWD) and physical activity (international physical activity questionnaire, iPAQ).

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)